Captopril
Inkcazo
I-Captopril (SQ-14534) inamandla, inhibitor ekhuphisanayo ye-angiotensin-converting enzyme (ACE).
I-In vitro
I-Captopril (i-SQ-14534) ibonakaliswe ukuba inobungozi obufanayo kunye neenzuzo zokufa kulabo be-diuretics kunye ne-beta-blockers kwizigulane ezixinzelelekileyo.I-Captopril (i-SQ-14534) ibonakaliswe ukulibazisa ukuqhubela phambili kwe-nephropathy yesifo seswekile, kwaye i-enalapril kunye ne-lisinopril zithintela ukuphuhliswa kwe-nephropathy kwizigulane ze-normoalbuminuric ezinesifo seswekile[1].Umlinganiselo olinganayo we-cis kunye ne-trans States ye-Captopril (SQ-14534) ikhona kwisisombululo kwaye i-enzyme ikhetha kuphela i-trans state ye-inhibitor ebonisa ukuhambelana kwe-architectural kunye ne-stereoelectronic kunye ne-substrate ebophelelayo i-groove [2].
I-MCE ayizange iqinisekise ngokuzimeleyo ukuchaneka kwezi ndlela.Zenzelwe ireferensi kuphela.
Ulingo lwezonyango
Inombolo ye-NCT | Umxhasi | Imeko | Umhla wokuqala | Isigaba |
NCT03179163 | IYunivesithi yasePenn State|Intliziyo yeSizwe, iLung, kunye neZiko leGazi (NHLBI) | Uxinzelelo lwegazi, kubalulekile | NgoJulayi 20, 2016 | Isigaba 1|Isigaba 2 |
NCT03660293 | IYunivesithi yaseTanta | Isifo seswekile, uhlobo loku-1 | Ngomhla woku-1 kuTshazimpuzi, ngo-2017 | Ayingeni |
NCT03147092 | Centro Neurológico de Pesquisa e Reabiitação, eBrazil | Uxinzelelo lwegazi | Uxinzelelo lwegazi | NgoFebruwari 1, 2018 | Isigaba sokuqala soku-1 |
NCT00252317 | IRigshospitalet, eDenmark | I-Aortic Stenosis | Novemba 2005 | Inqanaba lesi-4 |
NCT02217852 | Isibhedlele sase-West China | Uxinzelelo lwegazi | Agasti 2014 | Inqanaba lesi-4 |
NCT01626469 | Brigham kunye neSibhedlele sabaseTyhini | Uhlobo lwesi-2 seswekile iMellitus | Meyi 2012 | Isigaba 1|Isigaba 2 |
NCT00391846 | AstraZeneca | Ukungaphumeleli kwentliziyo|Ukungasebenzi kakuhle kwe-Venticular, eKhohlo | Okthobha 2006 | Inqanaba lesi-4 |
NCT00240656 | IYunivesithi yezoNyango yaseHebei | Uxinzelelo lwegazi, imiphunga | Okthobha 2005 | Inqanaba loku-1 |
NCT00086723 | IYunivesithi yaseNorthwestern|Iziko leSizwe loMhlaza (NCI) | Ithumba eliqinileyo labadala elingachazwanga, iProtocol ecacileyo | Julayi 2003 | Isigaba 1|Isigaba 2 |
NCT00663949 | IYunivesithi yaseShiraz yeSayensi yezoNyango | Isifo seswekile seNephropathy | NgoFebruwari 2006 | Isigaba 2|Isigaba 3 |
NCT01437371 | Isibhedlele saseYunivesithi, eClermont-Ferrand|Servier|LivaNova | Ukumelwa yintliziyo | Agasti 2011 | Inqanaba lesi-3 |
NCT04288700 | KwiYunivesithi yaseAin Shams | Infantile Hemangioma | Nge-1 kaOkthobha, 2019 | Inqanaba lesi-4 |
NCT00223717 | IYunivesithi yaseVanderbilt | Iziko lezoNyango leYunivesithi yaseVanderbilt | Uxinzelelo lwegazi | NgoJanuwari 2001 | Inqanaba loku-1 |
NCT02770378 | IYunivesithi yase-Ulm|Unyango oluthembekileyo loMhlaza | Ingxowa-mali ye-Anticancer, eBelgium | IGlioblastoma | EyeNkanga 2016 | Isigaba 1|Isigaba 2 |
NCT01761916 | Instituto Materno Infantil Prof. Fernando Figueira | I-Preeclampsia | NgoJanuwari 2013 | Inqanaba lesi-4 |
NCT01545479 | Instituto de Cardiologia do Rio Grande do Sul | Isifo sezintso | NgoJanuwari 2010 | Inqanaba lesi-4 |
NCT00935805 | Hospital de Clinicas de Porto Alegre|Conselho Nacional de Desenvolvimento Científico e Tecnológico|Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil | Isifo seswekile | Uxinzelelo lwegazi | Julayi 2006 |
|
NCT00742040 | Isibhedlele sabantwana abagulayo | Isifo sentliziyo | Agasti 2008 | Inqanaba lesi-2 |
NCT03613506 | IYunivesithi yaseWuhan | I-Radiotherapy Side Effect|Ukuthatha iCaptopril | Ngo-Oktobha 25, 2018 | Inqanaba lesi-2 |
NCT00004230 | IYunivesithi yaseNorthwestern|Iziko leSizwe loMhlaza (NCI) | Umhlaza | Okthobha 1999 | Inqanaba lesi-3 |
NCT00660309 | Novartis | Uhlobo lwesi-2 seswekile iMellitus | Epreli 2008 | Inqanaba lesi-4 |
NCT00292162 | I-NHS Greater Glasgow kunye neClyde | Ukungaphumeleli kweNtliziyo okuNgapheliyo | UFibrillation yeAtrial | NgoJanuwari 2007 | Ayingeni |
NCT01271478 | Coordinación de Investigación en Salud, Mexico | Ukukrala|Isigaba sokuphela-Isifo sezintso | Agasti 2009 | Inqanaba lesi-4 |
NCT04193137 | IYunivesithi yezoNyango yaseChongqing | I-Aldosteronism yokuqala | NgoNovemba 30, 2019 |
|
NCT00155064 | Isibhedlele seYunivesithi yeSizwe yaseTaiwan | Hyperaldosteronism | Julayi 2002 | Inqanaba lesi-4 |
NCT01292694 | IYunivesithi yaseVanderbilt | Iziko lezoNyango leYunivesithi yaseVanderbilt | Uxinzelelo lwegazi | Ukungaphumeleli okuNgenene okuZimelayo|IAtrophy yeeNkqubo ezininzi | Matshi 2011 | Inqanaba loku-1 |
NCT00917345 | Isibhedlele seYunivesithi yeSizwe yaseTaiwan|Novartis | I-Aldosteronism yokuqala | NgoJanuwari 2008 |
|
NCT00077064 | IQela loNyango lweRadiation Oncology|Iziko leSizwe loMhlaza (NCI)|NRG Oncology | Umhlaza wemiphunga|Iingxaki zemiphunga|iRadiation Fibrosis | NgoJuni 2003 | Inqanaba lesi-2 |
Ugcino
Umgubo | -20°C | Iminyaka emi-3 |
4°C | iminyaka eyi-2 | |
Kwi-solvent | -80°C | Iinyanga ezi-6 |
-20°C | Inyanga eyi-1 |
Ubume beMichiza
Isindululo18Iiprojekthi zoVavanyo loBulunga ezivunyiweyo4, kwaye6iiprojekthi ziphantsi kolwamkelo.
Inkqubo yolawulo lomgangatho wehlabathi ephucukileyo ibeke isiseko esiluqilima sokuthengisa.
Ukongamela umgangatho kutyhutyha umjikelo wobomi bemveliso ukuqinisekisa umgangatho kunye nesiphumo sonyango.
Iqela leMicimbi yoLawulo lobuGcisa lixhasa iimfuno zomgangatho ngexesha lesicelo nokubhaliswa.